See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum. It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with …
Six Months After Authorization, What Do We Know About Paxlovid? Read More »
May is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical industry can do more to address the mental health crisis. The stigma of mental health disorders is slowly disappearing, and that’s a very good thing. You see evidence of this everywhere: on TV and social …
How the Pharmaceutical Industry Can Turn the Tide on Mental Health Read More »
See article as it originally appeared in MedCity News. The pharmaceutical industry made more headlines in 2021 than in any other year in recent memory. And 2022 is set to be a monumental year as well. Here are three key themes that will define the year ahead. Biosimilar interchangeability In 2021 the FDA approved the …
It might seem like a lowest-net-cost formulary would be made up of clinically equivalent agents with the lowest overall cost. But in the complex world of drug pricing and pharmacy benefits, that is not the case. Lowest-net-cost formularies are a good way for organizations to lower their pharmacy spend. These formularies substitute clinically sound, chemically …
Want the Lowest-Net-Cost Drugs? Change Your Thinking on Disruption Read More »
What the Covid vaccine taught us, and how we can be better. See this article as it originally appeared in Inc. With Covid-19 vaccine progress ahead of targets, it’s clear that the pharmaceutical industry has come through in a big way when the country needed it most. The vaccines were developed, approved, and distributed on …
Can the Vaccine Rollout Guide Us to More Efficient Health Care? Read More »
Our healthcare system is extremely complex and increasing drug pricing transparency will be a big part of simplifying it in order to reduce costs. However, drug price data has to be easily digestible by consumers. The average American, and even healthcare professionals not directly involved in the payment and finance side of the business, are …
Hospital Price Transparency Rule Not Enough to Lower Drug Prices Read More »
Executive Summary Today, generics are widely available and more regulated, with improved quality compared to that of the not-so-distant past. The savings from generic drugs has surpassed $265 billion since 2008, and ninety-three percent (93%) of generic prescriptions are filled at a cost of twenty dollars ($20) or less. Unfortunately, not all treatment categories have …
Navigating the Complex World of Generics and Authorized Generics Read More »
Terms of Use | Privacy Policy | All trademarks herein are registered trademarks of their respective owners. | ©2020 RemedyOne | All rights reserved.
